Feasibility of canakinumab withdrawal in colchicine-resistant familial Mediterranean fever

OBJECTIVES: There is no consensus on canakinumab treatment tapering and discontinuation strategies in colchicine-resistant FMF patients. In this study, we aimed to establish a treatment management and discontinuation protocol in paediatric FMF patients treated with canakinumab. METHODS: Fifty-eight...

Descripción completa

Detalles Bibliográficos
Autores principales: Sener, Seher, Cam, Veysel, Batu, Ezgi Deniz, Kasap Cuceoglu, Muserref, Balik, Zeynep, Aliyev, Emil, Bayindir, Yagmur, Basaran, Ozge, Bilginer, Yelda, Ozen, Seza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Clinical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10629778/
https://www.ncbi.nlm.nih.gov/pubmed/36961326
http://dx.doi.org/10.1093/rheumatology/kead128

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10629778/
https://www.ncbi.nlm.nih.gov/pubmed/36961326
http://dx.doi.org/10.1093/rheumatology/kead128

Ejemplares similares